Filing metadata

Accession number
0001493152-21-003990
Form type
Form 3
Filer
Ayala Pharmaceuticals, Inc.
CIK
CIK 1100397
Filed
Feb 16, 2021
Reporting period
Feb 11, 2021
Description
Initial ownership

Explore SEC Filings Hub